by Kall Kwik WGC | Aug 11, 2015 | Free Library
August, 2015 SMM-130 Unintended Consequences Recent and continuing issues that the pharmaceutical industry has with business ethics remind us that good intentions can have unintended consequences. This article looks at how life science companies...
by Kall Kwik WGC | Jun 25, 2015 | Free Library
June, 2015 SMM-128 The Lasting Advantage A transforming market quickly renders existing assets and capabilities obsolete. In a life sciences market where technology, customers and competitors are evolving, organisational learning is the only...
by Kall Kwik WGC | Jun 25, 2015 | Free Library
June, 2015 SMM-129 Research Watch This Research Watch covers everything from personalised medicine, to new market entry, to alliances and networks.
by Kall Kwik WGC | Jun 15, 2015 | Free Library
June, 2015 SMM-127 Friend or Foe This article looks at the implications of co-evolutionary theory for pharma companies.
by Kall Kwik WGC | Jun 15, 2015 | Free Library
June, 2015 SMM-126 Critical Thinking Professor Brian D Smith assesses the Darwinian model of mutation in pharmaceutical companies.
by Kall Kwik WGC | Jun 15, 2015 | Free Library
May, 2015 SMM-125 Evolution of Excellence Many examples of excellence don’t stand the test of time. How can we better understand how firms become and remain excellent? And how might that understanding change the way we grow our own...
